Related Experiment Videos
Complement activation during cardiopulmonary bypass. Comparison of bubble and membrane oxygenators
The Journal of Thoracic and Cardiovascular Surgery
|February 1, 1986
Summary
Cardiopulmonary bypass using bubble oxygenators significantly increases complement activation and leukocyte sequestration. Using methylprednisolone or membrane oxygenators reduces these inflammatory responses during cardiac surgery.
Area of Science:
- Cardiovascular Surgery
- Immunology
- Biomaterials
Background:
- Cardiopulmonary bypass (CPB) is essential for cardiac surgery but can trigger inflammatory responses.
- Bubble oxygenators are known to activate the complement system and lead to leukocyte sequestration.
- The use of methylprednisolone or membrane oxygenators may mitigate these CPB-induced inflammatory effects.
Purpose of the Study:
- To compare the effects of bubble oxygenators (with and without methylprednisolone) and membrane oxygenators on complement activation and leukocyte sequestration during CPB.
- To evaluate the efficacy of methylprednisolone sodium succinate in reducing CPB-induced inflammation.
- To assess the inflammatory potential of membrane oxygenators versus bubble oxygenators.
Main Methods:
- A prospective randomized trial was conducted with 91 patients undergoing CPB.
- Patients were divided into three groups: bubble oxygenator alone (Group I), bubble oxygenator with methylprednisolone (Group II), and membrane oxygenator (Group III).
- Complement activation (C3a, C5a) and transpulmonary leukocyte sequestration were measured.
Main Results:
- Group I showed a significant increase in C3a levels during and after CPB.
- Groups II and III exhibited significantly lower C3a levels compared to Group I.
- Transpulmonary leukocyte sequestration was significantly reduced in Groups II and III compared to Group I.
Conclusions:
- Bubble oxygenators alone induce significantly more C3a activation and leukocyte sequestration during CPB.
- Pre-treatment with methylprednisolone or the use of a membrane oxygenator significantly attenuates these inflammatory responses.
- These findings suggest that alternative strategies can mitigate CPB-associated inflammation in cardiac surgery.